X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. Revenue 2018–2025
X4 Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- X4 Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 2.7 M, a 90.60% decrease year-over-year.
- X4 Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 35.3 M, a 3039.18% increase year-over-year.
- X4 Pharmaceuticals Inc. annual revenue for 2025 was 35.1 M, a 1273.21% increase from 2024.
- X4 Pharmaceuticals Inc. annual revenue for 2024 was 2.6 M.
- X4 Pharmaceuticals Inc. annual revenue for 2023 was 0.
- X4 Pharmaceuticals Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
X4 Pharmaceuticals Inc. Market Cap — FAQ
X4 Pharmaceuticals Inc. (XFOR) market cap over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XFOR's market cap history?
The chart and table above show X4 Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.